lung

The HLH Imaging Group: tech-powered teleradiology company making waves in NHS Lung Cancer Screening and beyond

Tech-enabled teleradiology company The HLH Imaging Group (HLH) has revolutionised end-to-end delivery of teleradiology by harnessing the capability of advanced AI technology and subspecialist expert radiologists to its innovative cloud-based screening IT platform. The HLH Imaging Group is demonstrating how combining human expertise and AI can significantly improve patient outcomes and healthcare efficiency at national […]

Read More

Continued impact by Compleo Health

Since being founded in 2021, Compleo Health has proven to be an aspirational and disruptive service provider within the diagnostic imaging space. As the focus on change in the NHS heightens, the need for providers to demonstrate value for money and present innovative solutions has increased. This pressure has seen many larger established providers deepen […]

Read More

Revolutionising lung health: how DEOS and Oxford University Hospitals are transforming early cancer detection

In the rapidly evolving field of healthcare, few advancements have had as significant an impact as the National Targeted Lung Health Check (TLHC) programme, now being rolled out across Oxfordshire. Spearheaded by Oxford University Hospitals NHS Foundation Trust and supported by innovative technology from DEOS Consultancy Limited, this initiative represents a major leap forward in […]

Read More

Revolutionising lung health: how DEOS and Oxford University Hospitals are transforming early cancer detection

In the rapidly evolving field of healthcare, few advancements have had as significant an impact as the National Targeted Lung Health Check (TLHC) programme, now being rolled out across Oxfordshire. Spearheaded by Oxford University Hospitals NHS Foundation Trust and supported by innovative technology from DEOS Consultancy Limited, this initiative represents a major leap forward in […]

Read More

AI-powered solutions to support lung cancer care are unveiled

Qure.ai unveiled its AI-powered lung cancer care continuum at the American Society of Clinical Oncology annual meeting in Chicago, Illinois, at the end of May. With solutions to identify, measure, manage and monitor, it is designed to support clinicians and advance developments for lung health in the pharmaceutical and medical device industries. “Lung cancer is […]

Read More

NHS Greater Glasgow and Clyde deploys AI for earlier detection of lung cancer

A digital health collaboration between the Scottish Government, University of Glasgow, Qure.ai and NHS Greater Glasgow and Clyde is rolling out the AI-powered chest x-ray reporting solution qXR across Glasgow. It is part of a national coordinated evaluation of AI in radiology to improve lung cancer patient outcomes, and to prove clinical and cost effectiveness. […]

Read More

AI project sites go-live to accelerate the diagnosis of lung cancer

LungIMPACT trial starts gathering real-world evidence with aim of saving lives now and into the future. A collaborative study between UK academia, NHS hospitals and AI innovator Qure.ai has commenced to gather real-world evidence of AI-assisted diagnosis of lung cancer, which could help save thousands of lives. The LungIMPACT trial is using Qure’s qXR (CE […]

Read More

Stay up to date with
RAD Magazine

Sign up for our newsletter.

We care about your data. Read our privacy policy.